CD83
CD83 antigen
Also known as: BL11, CD83_HUMAN, HB15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01151
- Gene
- CD83
- Ensembl
- ENSG00000112149
- Chromosome
- 6
- Canonical length
- 205 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a single-pass type I membrane protein and member of the immunoglobulin superfamily of receptors. The encoded protein may be involved in the regulation of antigen presentation. A soluble form of this protein can bind to dendritic cells and inhibit their maturation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>Q01151|CD83
1 MSRGLQLLLL SCAYSLAPAT PEVKVACSED VDLPCTAPWD PQVPYTVSWV KLLEGGEERM
61 ETPQEDHLRG QHYHQKGQNG SFDAPNERPY SLKIRNTTSC NSGTYRCTLQ DPDGQRNLSG
121 KVILRVTGCP AQRKEETFKK YRAEIVLLLA LVIFYLTLII FTCKFARLQS IFPDFSKAGM
181 ERAFLPVTSP NKHLGLVTPH KTELVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD83 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 198 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 198 nTPM
- tonsil: 66 nTPM
- lymph node: 48 nTPM
- lung: 38 nTPM
- thymus: 35 nTPM
- choroid plexus: 35 nTPM
Single-cell type
- cdc: 2,003 nCPM
- b-cells: 1,197 nCPM
- macrophages: 1,091 nCPM
- monocytes: 1,088 nCPM
- pdcs: 724 nCPM
- neutrophils: 633 nCPM
Immune cell
- naive B-cell: 31 nTPM
- non-classical monocyte: 30 nTPM
- memory B-cell: 20 nTPM
- intermediate monocyte: 19 nTPM
- myeloid DC: 9 nTPM
- T-reg: 6.2 nTPM
Brain region
- choroid plexus: 39 nTPM
- white matter: 36 nTPM
- pons: 33 nTPM
- hypothalamus: 33 nTPM
- medulla oblongata: 30 nTPM
- cerebral cortex: 26 nTPM
ReferencesPubMed · IEDB
Publications for CD83 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
2018 · J Immunol · RCR 0.5 · 13 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- CD4-positive, alpha-beta T cell differentiation
- defense response
- humoral immune response
- negative regulation of interleukin-4 production
- positive regulation of CD4-positive, alpha-beta T cell differentiation
- positive regulation of interleukin-10 production
- positive regulation of interleukin-2 production
- signal transduction
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD83 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD83 as an antibody target. Whether an autoantibody or antibody against CD83 could matter depends on whether native CD83 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD83 is annotated at the cell surface, where native CD83 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD83 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...